KB Financial Partners’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-25
Closed -$1K 628
2023
Q1
$1K Sell
25
-1
-4% -$27 ﹤0.01% 583
2022
Q4
$1K Sell
26
-33
-56% -$844 ﹤0.01% 578
2022
Q3
$1K Hold
59
﹤0.01% 570
2022
Q2
$2K Sell
59
-8,757
-99% -$307K ﹤0.01% 534
2022
Q1
$308K Buy
8,816
+677
+8% +$23.2K 0.09% 133
2021
Q4
$248K Buy
+8,139
New +$265K 0.07% 158
2021
Q3
Sell
-33
Closed -$1K 443
2021
Q2
$1K Buy
+33
New +$1.09K ﹤0.01% 607

Other funds holding OGN

KB Financial Partners's OGN Position: Q2 2023 in Review

KB Financial Partners sold out of Organon & Co (OGN) in Q2 2023, closing a stake of 25 shares — an estimated $1K sold.

KB Financial Partners first reported a position in OGN in Q2 2021 and held it in 7 quarters. The position peaked at $308K in Q1 2022. 727 funds tracked by Wall St. Rank hold OGN as of Q2 2023.

  • KB Financial Partners reported no remaining Organon & Co position as of Q2 2023 after selling out during the quarter.
  • KB Financial Partners sold 25 Organon & Co shares in Q2 2023, an estimated $1K.
  • KB Financial Partners first reported a position in Organon & Co in Q2 2021 and held it in 7 quarters.
  • KB Financial Partners's Organon & Co position peaked at $308K in Q1 2022.
  • 727 funds tracked by Wall St. Rank held Organon & Co as of Q2 2023.

Based on KB Financial Partners's 13F filing for Q2 2023, filed 15 Aug 2023.